Runben Biotechnology Co., Ltd. (SHA:603193)
22.25
-0.43 (-1.90%)
May 27, 2026, 3:00 PM CST
-43.91% (1Y)
| Market Cap | 9.00B -36.2% |
| Revenue (ttm) | 1.57B +13.0% |
| Net Income | 322.94M +4.6% |
| EPS | 0.80 +5.5% |
| Shares Out | 404.59M |
| PE Ratio | 27.83 |
| Forward PE | 23.92 |
| Dividend | 0.46 (2.03%) |
| Ex-Dividend Date | May 29, 2026 |
| Volume | 3,028,000 |
| Open | 22.55 |
| Previous Close | 22.68 |
| Day's Range | 21.82 - 22.74 |
| 52-Week Range | 20.28 - 42.61 |
| Beta | 0.41 |
| Analysts | Strong Buy |
| Price Target | 34.47 (+54.92%) |
| Earnings Date | Apr 23, 2026 |